Arbutus Biopharma CorporationABUSNASDAQ
LOADING
|||
Revenue Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
-65.98%
↓ 188% below average
Average (9y)
75.18%
Historical baseline
Range
High:613.33%
Low:-93.97%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | -65.98% |
| 2023 | -53.51% |
| 2022 | 255.11% |
| 2021 | 58.92% |
| 2020 | 15.02% |
| 2019 | 1.88% |
| 2018 | -44.86% |
| 2017 | 613.33% |
| 2016 | -93.97% |
| 2015 | 65.82% |